Search
Channel Therapeutics Corp
CHROAdd to Watchlist
1.350USD
0.0000.00%
Close 07/02, 13:00（ET）Quotes delayed by 15 min
8.35MMarket Cap
LossP/E TTM
Shareholding Stats
Updated: Sun, May 10
Updated: Sun, May 10
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Ligand Pharmaceuticals Inc
44.70%
Murchinson Ltd.
8.34%
Ikarian Capital LLC
7.62%
3I Management LLC
6.36%
Vanguard Capital Management, LLC
2.77%
Other
30.19%
Shareholders
Shareholders
Proportion
Ligand Pharmaceuticals Inc
44.70%
Murchinson Ltd.
8.34%
Ikarian Capital LLC
7.62%
3I Management LLC
6.36%
Vanguard Capital Management, LLC
2.77%
Other
30.19%
Shareholder Types
Shareholders
Proportion
Corporation
48.34%
Investment Advisor/Hedge Fund
17.52%
Hedge Fund
11.77%
Individual Investor
7.78%
Investment Advisor
4.19%
Private Equity
0.24%
Other
10.15%
Institutional Shareholding
Updated: Wed, Apr 1
Updated: Wed, Apr 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2026Q1
28
1.10M
32.89%
+302.04K
2025Q4
23
771.24K
24.99%
+360.35K
2025Q3
16
381.63K
12.44%
+261.36K
2025Q2
29
442.85K
25.62%
-75.15K
2025Q1
30
5.53M
87.25%
-737.83K
2024Q4
26
5.70M
94.59%
+2.29M
2024Q3
24
4.75M
78.78%
+1.42M
2024Q2
20
4.57M
77.26%
+1.20M
2024Q1
14
4.63M
79.55%
+4.63M
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
Ligand Pharmaceuticals Inc
1.50M
44.7%
--
--
Nov 24, 2025
Murchinson Ltd.
289.48K
8.63%
+9.48K
+3.39%
Dec 31, 2025
Ikarian Capital LLC
255.76K
7.62%
+193.31K
+309.53%
Dec 31, 2025
3I Management LLC
213.51K
6.36%
-86.49K
-28.83%
Dec 31, 2025
Balmoral Financial Group LLC
92.07K
2.74%
--
--
Nov 24, 2025
Boothbay Fund Management, LLC
80.68K
2.4%
+59.44K
+279.76%
Dec 31, 2025
J. Goldman & Co., L.P.
78.01K
2.32%
+78.01K
--
Dec 31, 2025
View more
Related ETFs
Name
Proportion
No Data